Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ana M Gonzalez-Angulo

Showing results (61-70 of 144) with videos related to

Pageof 15
Sort By:
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 21, 2015
Antiepileptic drug use improves overall survival in breast cancer patients with brain metastases in the setting of whole brain radiotherapyJay P Reddy, Shaheenah Dawood, Melissa Mitchell, et al.
Breast Cancer Research and Treatment|May 1, 2007
HER2 expression and efficacy of preoperative paclitaxel/FAC chemotherapy in breast cancerFabrice Andre, Chafika Mazouni, Cornelia Liedtke, et al.
The Oncologist|June 30, 2011
Prognostic impact of phosphorylated HER-2 in HER-2+ primary breast cancerNaoki Hayashi, Takayuki Iwamoto, Ana M Gonzalez-Angulo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 30, 2011
Loss of human epidermal growth factor receptor 2 (HER2) expression in metastatic sites of HER2-overexpressing primary breast tumorsNaoki Niikura, Jun Liu, Naoki Hayashi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 3, 2007
Residual ductal carcinoma in situ in patients with complete eradication of invasive breast cancer after neoadjuvant chemotherapy does not adversely affect patient outcomeChafika Mazouni, Florentia Peintinger, Shu Wan-Kau, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2008
Relationship between obesity and pathologic response to neoadjuvant chemotherapy among women with operable breast cancerJennifer K Litton, Ana M Gonzalez-Angulo, Carla L Warneke, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 24, 2009
Retrospective study of 18F-FDG PET/CT in the diagnosis of inflammatory breast cancer: preliminary dataSelin Carkaci, Homer A Macapinlac, Massimo Cristofanilli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2006
Prognostic value of pathologic complete response after primary chemotherapy in relation to hormone receptor status and other factorsValentina Guarneri, Kristine Broglio, Shu-Wan Kau, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 12, 2012
Gene expression, molecular class changes, and pathway analysis after neoadjuvant systemic therapy for breast cancerAna M Gonzalez-Angulo, Takayuki Iwamoto, Shuying Liu, et al.
Cancer|August 9, 2011
Effect of CYP2D6 polymorphisms on breast cancer recurrencePhuong K Morrow, Ruben Serna, Kristine Broglio, et al.
Pageof 15

Showing results (61-70 of 144) with videos related to

Sort By:
Pageof 15
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology|October 21, 2015
Antiepileptic drug use improves overall survival in breast cancer patients with brain metastases in the setting of whole brain radiotherapyJay P Reddy, Shaheenah Dawood, Melissa Mitchell, et al.
Breast Cancer Research and Treatment|May 1, 2007
HER2 expression and efficacy of preoperative paclitaxel/FAC chemotherapy in breast cancerFabrice Andre, Chafika Mazouni, Cornelia Liedtke, et al.
The Oncologist|June 30, 2011
Prognostic impact of phosphorylated HER-2 in HER-2+ primary breast cancerNaoki Hayashi, Takayuki Iwamoto, Ana M Gonzalez-Angulo, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 30, 2011
Loss of human epidermal growth factor receptor 2 (HER2) expression in metastatic sites of HER2-overexpressing primary breast tumorsNaoki Niikura, Jun Liu, Naoki Hayashi, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 3, 2007
Residual ductal carcinoma in situ in patients with complete eradication of invasive breast cancer after neoadjuvant chemotherapy does not adversely affect patient outcomeChafika Mazouni, Florentia Peintinger, Shu Wan-Kau, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 2, 2008
Relationship between obesity and pathologic response to neoadjuvant chemotherapy among women with operable breast cancerJennifer K Litton, Ana M Gonzalez-Angulo, Carla L Warneke, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 24, 2009
Retrospective study of 18F-FDG PET/CT in the diagnosis of inflammatory breast cancer: preliminary dataSelin Carkaci, Homer A Macapinlac, Massimo Cristofanilli, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 1, 2006
Prognostic value of pathologic complete response after primary chemotherapy in relation to hormone receptor status and other factorsValentina Guarneri, Kristine Broglio, Shu-Wan Kau, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 12, 2012
Gene expression, molecular class changes, and pathway analysis after neoadjuvant systemic therapy for breast cancerAna M Gonzalez-Angulo, Takayuki Iwamoto, Shuying Liu, et al.
Cancer|August 9, 2011
Effect of CYP2D6 polymorphisms on breast cancer recurrencePhuong K Morrow, Ruben Serna, Kristine Broglio, et al.
Pageof 15